SCHEMBL5254880

SCHEMBL5254880

CCNc1nccc(-c2cc(OC(=O)OCC)c(=O)[nH]n2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 1/20 0.42
▸ PDPK1 O15530 1/20 0.41
▸ AKT3 Q9Y243 1/20 0.34
▸ BRAF P15056 2/20 0.34
▸ MKNK1 Q9BUB5 1/20 0.34
▸ AURKA O14965 2/20 0.33
▸ CDK1 P06493 2/20 0.33
▸ CDK2 P24941 2/20 0.33
▸ CDK7 P50613 2/20 0.33
▸ CDK9 P50750 2/20 0.33
▸ AURKB Q96GD4 2/20 0.33
▸ CDK4 P11802 1/20 0.33
▸ CDC7 O00311 1/20 0.33
▸ JMJD6 Q6NYC1 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ EIF2AK2 P19525 2/20 0.32
▸ CDK5 Q00535 1/20 0.32
▸ CDK5R1 Q15078 1/20 0.32
▸ PIK3CA P42336 1/20 0.32
▸ PKM P14618 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5257150 0.88 PDPK1 (0.43) GSK3BPDPK1AKT3BRAFMKNK1
SCHEMBL2946867 0.83 GSK3B (0.49) GSK3BPDPK1JMJD6POLBCDK5
SCHEMBL2947276 0.78 GSK3B (0.52) GSK3BPDPK1AKT3BRAFMKNK1
SCHEMBL5253672 0.77 PDPK1 (0.39) GSK3BPDPK1AKT3BRAFPOLB
SCHEMBL5237798 0.69 AKT3 (0.44) GSK3BAKT3BRAFAURKAAURKB
SCHEMBL5230846 0.69 GSK3B (0.76) GSK3BCDK2EIF2AK2
SCHEMBL4857179 0.68 GSK3B (0.65) GSK3BPDPK1CDC7EIF2AK2
SCHEMBL2944211 0.67 IDH1 (0.43) GSK3BPDPK1AKT3BRAFEIF2AK2
SCHEMBL25330999 0.65 SYK (0.48) CDK2RAB9A
SCHEMBL4854990 0.65 AURKB (0.46) GSK3BPDPK1AKT3AURKAAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1725543-B1 4-BENZIMIDAZOL-2-YL-PYRIDAZINE-3-ONE-DERIVATIVES, PRODUCTION AND USE THEREOF IN MEDICAMENTS SANOFI AVENTIS DEUTSCHLAND (DE) 2007-11-28 — — EP disclosed
EP-1725543-A1 4-BENZIMIDAZOL-2-YL-PYRIDAZINE-3-ONE-DERIVATIVES, PRODUCTION AND USE THEREOF IN MEDICAMENTS Sanofi-Aventis Deutschland GmbH (DE) 2006-11-29 — — EP disclosed
WO-2005085230-A1 4-BENZIMIDAZOL-2-YL-PYRIDAZINE-3-ONE-DERIVATIVES, PRODUCTION AND USE THEREOF IN MEDICAMENTS SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2005-09-15 — — WO disclosed
Send feedback